Neochem Bio Solutions Ltd (NEOCHEM) — shareholding pattern, promoter holding, financials and share price
About Neochem Bio Solutions Ltd (NEOCHEM)
Neochem Bio Solutions Ltd operates in the Other Industrial Products industry, within the Capital Goods sector. It trades on the NSE as NEOCHEM and on the BSE under scrip code 95754. Its ISIN is INE21UM01018.
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals. [1]
Listed peers in Other Industrial Products: Expo Engineering and Projects Ltd, De Neers Tools Ltd, Envirotech Systems Ltd, Alphalogic Industries Ltd, Rappid Valves India Ltd, W H Brady & Co Ltd.
Valuation & Returns
10 Jul 2026At ₹91.05 a share on 10 Jul 2026, Neochem Bio Solutions Ltd (NEOCHEM) was valued at a price-to-earnings ratio of 20.28x against an industry P/E of 37x and a price-to-book of 2.17x on a book value of ₹41.89 per share. Solomo computes return on equity of 39.24% and return on capital employed of 24.86% from filed results.
- P/E
- 20.28x
- Industry P/E
- 37x
- P/B
- 2.17x
- EPS (TTM)
- ₹6.64
- Book value / share
- ₹41.89
- ROE
- 39.24%
- ROCE
- 24.86%
- Debt / equity
- 1.8x
- Dividend yield
- 0%
- 52-week range
- ₹63 – ₹121
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2025In the year ended Mar 2025, Neochem Bio Solutions Ltd (NEOCHEM) reported revenue of ₹84.17 crore, net profit of ₹7.75 crore and earnings per share of ₹11.61. That compares with revenue of ₹61.15 crore and net profit of ₹1.8 crore in Mar 2024. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹65 crore and net profit ₹7 crore (standalone).
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Revenue (₹ cr) | 48.19 | 61.15 | 84.17 |
| Net profit (₹ cr) | 1.07 | 1.8 | 7.75 |
| EPS (₹) | 1.97 | 2.7 | 11.61 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 20.10% | 37.65% |
| Profit growth | 97.13% | 330.56% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 66.72% of Neochem Bio Solutions Ltd (NEOCHEM). Market capitalisation was ₹156 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2026.
Largest disclosed public shareholders in Mar 2026: Sanshi Fund-I 2.99%, Mavira Growth Opportunities Fund 2.92%, Finavenue Capital Trust - Finavenue Growth Fund 2.66%, Sheetal Sagar Builders & Developers Private Limited 2.21%, Invicta Continuum Fund I 1.93%, Venturex Fund I 1.8%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 66.72% | - | - | - | - |